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Abstract
Background:  Toxoplasmosis in immuno-compromised hosts manifests primarily as a life
threatening condition, toxoplasmic encephalitis. However, there is scarce information about the
magnitude of Toxoplasma gondii infection among HIV-infected people in Ethiopia. This study was,
therefore, conducted to determine the sero-prevalence of T. gondii infection among HIV-infected
and HIV-uninfected subjects.
Findings: Sera were collected from people with and without HIV infection for the purpose of
studying hepatitis B virus (HBV) at St. Paul Hospital, Addis Ababa, Ethiopia from 24 January 2007
to 15 February 2007. Among these sera, the first 330 consecutive sera, 165 from each HIV sero-
group, were selected and tested for anti-T. gondii IgG antibodies using Enzyme Linked
Immunosorbent Assay. The seroprevalence of Toxoplasma infection was assessed against socio-
demographic characteristics, HIV and HBV serostatus and HBV-related risk factors. The overall
sero-prevalence of latent T. gondii infection among the study subjects was 90.0%. Toxoplasma
infection was observed with respective prevalence of 93.3% and 86.7% among HIV-infected and
HIV-uninfected people. Though Toxoplasma infection seems to be influenced by age, gender and
HIV serostatus, only HBV serostatus was significantly associated (OR 2.71, CI 1.12 to 6.57) in
multivariate logistic regression analysis.
Conclusion: The seroprevalence of latent T. gondii infection is high and similar by HIV status.
Educating people to prevent acquisition of new Toxoplasma infection and minimizing the risk of
disease manifestations among HIV-Toxoplasma co-infected individuals is important.
Background
Toxoplasma gondii is one of the most prevalent protozoan
parasites of man and livestock [1]. It has been estimated
that up to one third of the world's population is infected
by T. gondii [2]. Most infections among humans occur by
eating undercooked or raw meat containing tissue cysts or
by exposure to oocysts through ingestion of contaminated
foods and drinks with cat's faeces [3-5]. Other modes of
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transmission include the transplacental route, blood
product transfusion and tissue transplantation [6,7].
In vast majority of immunocompetent human host, T.
gondii ensue a latent infection characterized by the persist-
ence of the organism in tissues (primarily brain, skeletal
muscle, and heart) without causing disease [8]. However,
in chronically infected individuals who develop defects in
cell-mediated immunity a symptomatic disease more
likely occurs as a result of reactivation of latent infection
[9,10]. Toxoplasmosis among Acquired Immunodefi-
ciency Syndrome (AIDS) patients manifests primarily as a
life threatening condition, toxoplasmic encephalitis (TE)
[9-11]. Early diagnosis and appropriate management of
toxoplasmosis decreases the incidence rates of TE; subse-
quently reduce morbidity and mortality among HIV
infected individuals [7].
In Ethiopia, up to 80% prevalence of Toxoplasma infection
has been reported in different risk groups [12-15].
Although latent Toxoplasma  infection has great impor-
tance among HIV infected people, it has been poorly stud-
ied. Therefore, this study was conducted to determine the
sero-prevalence of latent T. gondii infection among HIV-
infected and HIV-uninfected subjects in order to get some
baseline information, from which clinical implication
may be drawn.
Methods
From 24 January 2007 to 15 February 2007, blood sam-
ples were collected from a total of 305 HIV-positive and
315 HIV-negative clients seeking either HIV or immuno-
logical testing at St. Paul's Hospital, Addis Ababa, Ethio-
pia. Parts of separated sera were originally used for
studying seroprevalence of hepatitis B virus (HBV) infec-
tion and leftover samples were stored at -70°C for further
investigations. Detailed description of methods used to
study HBV infection was published elsewhere [16].
HIV and HBV sero-status of all samples were, therefore,
known and selected sera from each HIV serogroup were
used for the purpose of studying seroprevalence of Toxo-
plasma infection. In the present study, because of limited
regent kits, we only included the first 330 consecutive
serum samples, 165 from each HIV sero-group.
Laboratory investigation of Toxoplasma infection was car-
ried out with in six months after initial blood collection.
Frozen sera were thawed at room temperature and those
having unsuitable appearance in terms of turbidity and
hemolysis were not included. Sera were tested in duplicate
for anti-Toxoplasma  IgG antibody using the Enzyme
Linked Immunosorbent Assay (BioCheck, Inc, CA, USA).
Positive and negative controls were included per each
batch of test run to ensure kits were working properly and
technical procedures were carried out correctly. As per the
instruction of the manufacturer, the mean absorbance
value of each sample was divided by the cut - off calibrator
mean value to obtain a Toxo G Index. A sample was con-
sidered positive for anti-Toxoplasma IgG antibody when-
ever a Toxo G Index value is equal or greater than 1.0 (>
32 IU/ml).
Toxoplasma  infection was assessed against socio-demo-
graphic characteristics, HIV and hepatitis B core antibody
(anti-HBc) serostatus. HBV-related risk factors including
history of blood transfusion, tattooing, blood letting,
multiple sexual partners, and surgery was also analyzed if
they have association with Toxoplasma infection.
Data entry and analysis was performed using SPSS Ver-
sion-12 software. Summaries were presented in terms of
mean, range and percentage as appropriate. Differences in
proportions were evaluated by Pearson's Chi-square test.
In cases in which more than 20% of the expected values
were less than 5, Fisher's exact test was used in lieu of chi-
square test. Bivariate and Multivariate logistic regression
analyses were used to assess the crude and adjusted effect
of HIV and other correlates on Toxoplasma infection. Odds
ratio was used to measure the strength of association
between the Toxoplasma infection and its correlates. A sta-
tistical test result was considered significant whenever a p-
value was < 0.05.
Institutional ethical clearance and appropriate written
informed consent was obtained from each participant to
use surplus sera for the present study.
Results
A total of 330 sera were included for studying sero-preva-
lence of latent Toxoplasma infection among people with
and without HIV infection. Half of the samples (50%)
were HIV positives and 44.8% (148/330) had anti-HBc
marker. The mean age of HIV infected participants was 35
years (range 20-66 years; SD 9.3) compared with mean
age of 25 years (range 17-64 years; SD 7.3) in HIV unin-
fected clients. The male to female ratio was 0.8:1 in HIV
positive and 1:1 in HIV negative individuals.
The cumulative sero-prevalence of anti-Toxoplasma  IgG
antibody among the study subjects was 90.0% (297/330).
In bivariate analysis, rate of Toxoplasma infection was sig-
nificantly higher among males than females (93.6% ver-
sus 86.6%; p = 0.04). In addition, rate of Toxoplasma
infection was shown to increase significantly with age (p
= 0.003) (Table 1).
The prevalence of latent Toxoplasma infection was 93.3%
(154/165) among HIV positive and 86.7% (143/165)
among HIV negative participants. This difference was alsoBMC Research Notes 2009, 2:213 http://www.biomedcentral.com/1756-0500/2/213
Page 3 of 5
(page number not for citation purposes)
statistically significant in bivariate analysis (p = 0.04).
Regardless of their HIV status, anti-Toxoplasma IgG anti-
body was more frequently detected in sera with anti-HBc
antibody compared with those with no anti-HBc serolog-
ical marker (95.3% verses 85.7%, p = 0.004). However,
similar rate of anti-Toxoplasma  IgG antibodies was
Table 1: Sero-prevalence of anti-Toxoplasma IgG antibody in relation to socio-demographic characteristics of the study subjects, Addis 
Ababa, 2007.
Characteristics Total (%) Number (%) positive for anti-Toxoplasma IgG antibody P-value
Residence
Rural 24 (7.3) 24 (100) 0.15
Urban 306 (92.7) 273 (89.2)
Sex
Male 156 (47.3) 146 (93.6) 0.04
Female 174 (52.7) 151 (86.8)
Age (years)
17-24 106 (32.1) 87 (82.1) 0.003
25-34 132 (40.0) 122 (92.4)
≥ 35 92 (27.9) 88 (95.7)
Marital status
Married 112 (33.9) 105 (93.8) 0.07
Single 167 (50.6) 144 (86.2)
Divorced/Widowed 51 (15.5) 48 (94.1)
Religion
Christian 286 (86.7) 254 (88.8) 0.10
Muslim 44 (13.3) 43 (97.7)
Ethnicity
Amhara 148 (44.8) 131 (88.5) 0.70
Oromo 94 (28.5) 84 (89.4)
Gurage 55 (16.7) 51 (92.7)
Other 33 (10.0) 31 (93.9)
Occupation
Gov't/private employee 82 (24.8) 75 (91.5) 0.17
Housewife/house maid 56 (17.0) 51 (91.1)
Student 59 (17.9) 48 (81.4)
Merchant 40 (12.1) 38 (95.0)
No work 93 (28.2) 85 (91.4)
Educational status Educational stat
Illiterate 37 (11.2) 36 (97.3) 0.09
Primary school 117 (35.5) 108 (92.3)
Secondary school and above 176 (53.3) 153 (86.9)
Table 2: Multivariate analysis on seemingly significant predictors of T. gondii infection in bivariate analysis, Addis Ababa, 2007
Characteristics Crude odds ratio
(95% confidence interval)
Adjusted odds ratio (95% confidence interval) P-value
Sex
Female 1 1
Male 2.22 (1.02-4.83) 1.9 (0.84-4.32) 0.13
Age (years)
17-24 1 1
25-34 2.66(1.18-6.01) 2.33 (0.93-5.81) 0.07
≥ 35 4.81(1.57-14.70) 2.96 (0.81-10.81) 0.10
HIV status
Negative 1
positive 2.15 (1.01-4.60) 1.32 (0.52-3.33) 0.56
Anti-HBc status
Negative 1 1
Positive 3.56(1.41-7.97) 2.71 (1.12-6.57) 0.03BMC Research Notes 2009, 2:213 http://www.biomedcentral.com/1756-0500/2/213
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detected in sera positive for both HBV and HIV compared
to those with HBV alone (48.7% versus 46.2%, p > 0.05).
Any of HBV-related risk factors analyzed to have associa-
tion with Toxoplasma infection were not found to be sig-
nificant.
In further analysis, after adjustment for those significantly
associated variables using the multivariate logistic regres-
sion, age, gender and HIV status were not found to affect
rate of Toxoplasma infection. However, sera with anti-HBc
antibody were shown more likely to have anti-Toxoplasma
IgG antibody (OR 2.71, CI 1.12 to 6.57) (Table 2).
Discussion
The sero-prevalence of anti-Toxoplasma  IgG antibody
among HIV-infected and HIV-uninfected participants was
determined in the present study. The overall prevalence
rate of latent T. gondii infection was found to be 90%. The
high prevalence of anti-Toxoplasma IgG antibody observed
in this hospital based study was in agreement with the
result of a previous survey carried out in the general pop-
ulation of Ethiopia (75%) [13]. Similar sero-prevalence of
T. gondii infection (80%) was also reported in a study,
which involved HIV-infected and HIV-uninfected people
in Addis Ababa [15]. The high sero-prevalence of latent
Toxoplasma infection among the study population seems
reasonable as raw or insufficiently cooked meat prepared
in a various favorite cultural food is consumed. In addi-
tion, cats are abundant to cause environmental contami-
nation and the climate is favorable to favor survival of the
parasite.
In this study, sero-prevalence of latent T. gondii infection
was shown to increase with age though the difference was
not statistically significant. Similarly, no association
between prevalence of latent Toxoplasma infection and age
was reported elsewhere [17]. In contrast, significantly
higher risk of having latent Toxoplasma  infection was
observed with increasing age [18,19]. The non-significant
effect of age on T. gondii infection in our study subjects
may suggest that exposure was irrespective of the risk
behaviors pertinent to specific age group.
Moreover, the present study showed that HIV-positive and
HIV-negative subjects had similar exposure to T. gondii
infection, as reported by others [15,17,18]. The high prev-
alence of latent T. gondii infection in these risk groups,
particularly among HIV-infected people, is of great con-
cern. Evidences have shown that high prevalence of latent
T. gondii infection and level of immunodeficiency in a
given population are directly related to the incidence of TE
[7,20]. It has been estimated that approximately one-third
of HIV positive people with latent T. gondii infection will
develop toxoplasmosis [11]. Accordingly, high incidence
rate of TE in our study population is expected unless pre-
ventive measures are undertaken.
However, our result indicating the more frequent occur-
rence of latent T. gondii infection among people with anti-
HBc antibody needs further study, as a similar observation
is not yet reported, in which additional results may con-
firm or challenge our finding. The lack of association
between  Toxoplasma  serostatus and HBV-related risk-
behaviors including blood transfusion may be the role of
these routes in the transmission of Toxoplasma infection
was non-significant among the study population.
Finally, because this study was not specifically designed to
study toxoplasmosis, we missed data on basic risk factors
such as cat ownership, dietary habits, soil exposure and
other important risk factors for disease acquisition. More-
over, because of limited resources, sufficient number of
sera was not included so that the study has lower statisti-
cal power. Our findings, therefore, should be interpreted
in light of the study limitations.
In conclusion, the sero-prevalence of latent T. gondii infec-
tion was high and similar among HIV-infected and HIV-
uninfected people. Therefore, burden of T. gondii infec-
tion should not be overlooked and educating people to
prevent acquisition of new infection has great importance.
Efforts should also be made to minimize the risk of sub-
sequent reactivation and disease manifestation among
HIV-positive people with latent Toxoplasma infection.
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